Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Boffito

Showing results (91-100 of 301) with videos related to

Pageof 31
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2012
Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategiesAlessandro Schipani, Laura Dickinson, Marta Boffito, et al.
Journal of the International AIDS Society|November 15, 2014
Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013Katie McFaul, Charlotte Lim, Rachael Jones, et al.
Brain Sciences|August 14, 2019
Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cARTJaime H Vera, Margherita Bracchi, Jasmini Alagaratnam, et al.
Vascular Health and Risk Management|May 14, 2009
Prevention of atherosclerosis in patients living with HIVFerruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, et al.
Sexually Transmitted Infections|February 13, 2025
Real-world experience of renal outcomes and management of PrEP users with estimated glomerular filtration rates less than 60 mL/min/1.73 m<sup>2</sup>Victoria Tittle, Nicolo Girometti, Jonathan Joseph Goodfellow, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcomaMarta Boffito, Patrick G Hoggard, David J Back, et al.
AIDS (London, England)|May 19, 2015
Transmitted antiretroviral resistance in a large HIV directorate 2011-2014: a responseKatie M McFaul, Charlotte Lim, Rachael Jones, et al.
Plos One|May 13, 2022
Prevalence, severity, and risk factors of disability among adults living with HIV accessing routine outpatient HIV care in London, United Kingdom (UK): A cross-sectional self-report studyDarren A Brown, Kelly K O'Brien, Richard Harding, et al.
Circulation Research|October 1, 2020
HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet CrosstalkAkif A Khawaja, Kirk A Taylor, Andrew O Lovell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2002
Alpha 1-acid glycoprotein levels in human immunodeficiency virus-infected subjects on antiretroviral regimensMarta Boffito, Katiusha Sciole, Riccardo Raiteri, et al.
Pageof 31

Showing results (91-100 of 301) with videos related to

Sort By:
Pageof 31
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2012
Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategiesAlessandro Schipani, Laura Dickinson, Marta Boffito, et al.
Journal of the International AIDS Society|November 15, 2014
Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013Katie McFaul, Charlotte Lim, Rachael Jones, et al.
Brain Sciences|August 14, 2019
Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cARTJaime H Vera, Margherita Bracchi, Jasmini Alagaratnam, et al.
Vascular Health and Risk Management|May 14, 2009
Prevention of atherosclerosis in patients living with HIVFerruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, et al.
Sexually Transmitted Infections|February 13, 2025
Real-world experience of renal outcomes and management of PrEP users with estimated glomerular filtration rates less than 60 mL/min/1.73 m<sup>2</sup>Victoria Tittle, Nicolo Girometti, Jonathan Joseph Goodfellow, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcomaMarta Boffito, Patrick G Hoggard, David J Back, et al.
AIDS (London, England)|May 19, 2015
Transmitted antiretroviral resistance in a large HIV directorate 2011-2014: a responseKatie M McFaul, Charlotte Lim, Rachael Jones, et al.
Plos One|May 13, 2022
Prevalence, severity, and risk factors of disability among adults living with HIV accessing routine outpatient HIV care in London, United Kingdom (UK): A cross-sectional self-report studyDarren A Brown, Kelly K O'Brien, Richard Harding, et al.
Circulation Research|October 1, 2020
HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet CrosstalkAkif A Khawaja, Kirk A Taylor, Andrew O Lovell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2002
Alpha 1-acid glycoprotein levels in human immunodeficiency virus-infected subjects on antiretroviral regimensMarta Boffito, Katiusha Sciole, Riccardo Raiteri, et al.
Pageof 31